Dr. Mehmet Bilen, MD
Claim this profileEmory University Hospital/Winship Cancer Institute
Studies Prostate Cancer
Studies Kidney Cancer
16 reported clinical trials
47 drugs studied
Area of expertise
1Prostate Cancer
Stage IV
Stage III
2Kidney Cancer
Stage IV
HBsAg negative
HBV DNA negative
Affiliated Hospitals
Clinical Trials Mehmet Bilen, MD is currently running
ACR-368
for Ovarian Cancer
This trial tests a new drug, ACR-368, alone or with a small dose of another drug, gemcitabine, in patients whose cancers don't respond to standard treatments. A special test helps decide which treatment might work best for each patient. Gemcitabine has been used with other drugs for various cancers, including pancreatic, lung, ovarian, and breast cancers.
Recruiting1 award Phase 210 criteria
Combination Immunotherapy
for Kidney Cancer
This trial is testing two new drugs, botensilimab and balstilimab, in patients with advanced kidney cancer who haven't been treated before. The new drugs aim to help the immune system better recognize and attack cancer cells. The study will compare these treatments over several months.
Recruiting1 award Phase 212 criteria
More about Mehmet Bilen, MD
Clinical Trial Related3 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Mehmet Bilen, MD has experience with
- Nivolumab
- Ipilimumab
- Cabozantinib S-malate
- Lenvatinib
- Pembrolizumab
- Enfortumab Vedotin
Breakdown of trials Mehmet Bilen, MD has run
Prostate Cancer
Kidney Cancer
Renal Cell Carcinoma
Bladder Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mehmet Bilen, MD specialize in?
Mehmet Bilen, MD focuses on Prostate Cancer and Kidney Cancer. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are Stage III.
Is Mehmet Bilen, MD currently recruiting for clinical trials?
Yes, Mehmet Bilen, MD is currently recruiting for 8 clinical trials in Atlanta Georgia. If you're interested in participating, you should apply.
Are there any treatments that Mehmet Bilen, MD has studied deeply?
Yes, Mehmet Bilen, MD has studied treatments such as Nivolumab, Ipilimumab, Cabozantinib S-malate.
What is the best way to schedule an appointment with Mehmet Bilen, MD?
Apply for one of the trials that Mehmet Bilen, MD is conducting.
What is the office address of Mehmet Bilen, MD?
The office of Mehmet Bilen, MD is located at: Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia 30322 United States. This is the address for their practice at the Emory University Hospital/Winship Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.